The global Non-Sterile Liquids/Suspensions Market held a valuation of USD 2.6 Billion in 2022, and it is further projected to expand at a CAGR of 6.5% over the forecasted years. According to a recent study by Future Market Insights, the oral dosage form is leading the market with a share of about 29.5% in the year 2022, within the global market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 2.6 Billion |
| Market Value 2033 | USD 5.2 Billion |
| CAGR 2023 to 2033 | 6.5% |
| Market Share of Top 5 Countries | 53.0% |
| Key Market Players | AbbVie Pharmaceutical Contract Manufacturing, Aenova Group, APPCO Pharmaceutical Corporation, Atral Pharmaceutical, Aurigene Pharmaceutical Services (Dr. Reddy’s), Biological E. Ltd., BioPlus Life Sciences, Bora Pharmaceuticals, Cambrex Corporation, COC Farmaceutici, Contract Pharmaceuticals Limited (CPL), DPT Laboratories, Ltd., Eurofins, JGL d.d., Mikart, PharmaVision (Vizyon Holding), Pierre Fabre, TriRx Pharmaceutical Services, UI Pharmaceuticals, Wasdell Group, Aphena Pharma, and Syngene International |
Active pharmaceutical ingredients (API) are dissolved in aqueous and non-aqueous solvents, suspended in suitable media, or incorporated into oil or water phases to create liquid dosage forms.
As a result, there are many different formulations of pharmaceutical liquids. Liquids that are not sterile are prepared in settings that are clean but not entirely sterile. These non-sterile liquid pharmaceuticals can be applied internally or externally.
An oral or topical route of drug administration can be used to provide a non-sterile liquid dose form. Moreover, liquid dosage forms provide advantages over other specialized dosage forms, including better patient compliance, quicker absorption, and more dosing flexibility.
The global sales of the market are anticipated to rise at a CAGR of 6.5% between 2023 and 2033, owing to the various applications in a wide range of medication formulations.
The demand for these products is increasing with respect to the pediatric and geriatric formulations and apart from this, the convenience and compliance provided by the products like mouth washes, gels, creams in reference to the way they are applied or consumed is something which fuels the growth of this market.
The global market holds around 7.3% share of the overall global solvent market with a value of around USD 35.6 Billion, in 2022.
Non-sterile liquids/suspensions can be used to deliver a variety of medications, including prescription drugs, non-prescription drugs, vitamins, dietary supplements, and nutraceuticals. As the population ages, there is a growing demand for formulations that address the specific needs of the elderly. Pediatric formulations are also gaining traction, driven by the need for dosage forms that are easier to administer in children, example oral dosage forms.
Pharmaceutical formulations, such as oral syrups, cough medicines, and other liquid drugs, frequently contain non-sterile liquids and suspensions. The demand for medicines may be influenced by the expanding access to healthcare in emerging nations, the rising prevalence of chronic diseases, and the expanding use of non-sterile fluids or suspensions.
It is also typical practice to produce nutraceuticals and nutritional supplements, such as vitamins, minerals, and botanical extracts, using non-sterile liquid or suspension formulations. The demand for non-sterile liquid or suspension formulations in this sector may rise as a result of rising consumer knowledge of the advantages of nutraceuticals and dietary supplements for health and wellness.
The aforementioned factors are expected to cause the global market to expand swiftly and reach an estimated value of USD 5.2 Billion in 2033.
Due to ease of administration, better taste, and easier swallowing, many consumers, especially kids and elderly patients, may choose liquid formulations over solid dose forms like tablets or capsules. This can result in a rise in demand for non-sterile suspension or liquid formulations. This growing preference of liquid formulations would present lucrative opportunities for the market in the coming years.
Moreover, the creation of non-sterile liquids or suspensions with improved drug stability, bioavailability, and therapeutic efficacy may be made possible by the development of innovative drug delivery technologies like nanotechnology, liposomes, and microencapsulation.
The market for non-sterile liquid or suspension formulations may be stimulated by these developments. In fact, companies today are utilizing cutting-edge technologies to improve both patient compliance and the bioavailability of dose forms.
Non-sterile liquid or suspension formulations may need to adhere to stringent regulatory criteria, such as those for quality assurance, safety, labeling, and manufacturing procedures. The market may be constrained by meeting these legal standards because they can be time-consuming and expensive, especially for startups or smaller firms.
Other than this, in comparison to solid dosage forms, non-sterile liquids or suspensions may have a shorter shelf life because they may be more prone to deterioration, microbial development, and other stability issues. This could shorten the shelf life of non-sterile liquid or suspension items, which might lead to product waste and higher expenditures for product expiry or recalls.
The USA dominated the North American region with market share of around 23.3% in the global market in 2022.
The USA market for non-sterile liquids/suspensions is driven by several factors, including the increasing demand for oral and topical dosage forms, the need for customized solutions that are designed for palatability and patient compliance, and the cost-effectiveness of non-sterile formulations compared to sterile formulations.
The USA market is characterized by a high level of innovation and technological advancement, which drives the development of new and improved non-sterile liquid/suspension formulations. The use of advanced technologies such as nanotechnology, microencapsulation, and spray drying can improve the stability, bioavailability, and efficacy of non-sterile liquid/suspension formulations.
Germany held a market share of 4.9% in 2022 in the global market. Non-sterile liquids/suspensions are frequently used to treat a variety of medical conditions such as cough, cold, allergies, and pain relief. The rising demand for OTC medications is propelling this market forward in this region.
With a focus on enhancing the patient experience and medication adherence, there is an increasing emphasis on patient-centric treatment in Germany. Non-sterile liquid or suspension formulations may have benefits for patients in terms of dosing flexibility, ease of administration, and patient convenience, all of which are consistent with patient-centric care paradigms.
The elderly population in Germany may have particular demands and preferences when it comes to the administration of medications. Older adults who may have trouble swallowing pills or capsules may prefer non-sterile liquid or suspension forms, which could increase demand for these formulations.
India had a market share of 8.8% in the global market in 2022. India's population is large and growing, which is driving demand for non-sterile liquids/suspensions. Chronic diseases such as diabetes, cardiovascular disease, and cancer are becoming more common in India.
With a population of over 1.3 Billion people, India has a high demand for pharmaceutical products, including non-sterile liquids/suspensions. The increasing population and urbanization in India have led to a rise in the prevalence of diseases and health conditions, which has increased the demand for medications.
The oral dosage form held a market share of 29.5% in the global market in 2022.
For patients who might have trouble swallowing solid dosage forms like pills or capsules, non-sterile liquid or suspension formulations are frequently simple to administer. They are thus especially well-suited for certain patient groups, including kids, the elderly, and people who have trouble swallowing or who have other medical issues that make it difficult to take solid dosage forms.
Many patients prefer liquid or suspension formulations due to their ease of use, convenience, and familiarity. This can contribute to the wide acceptance of oral dosage forms in the non-sterile liquid or suspensions market, as patient preference and convenience are important factors in medication selection and adherence.
The human medication segment held a market share of 40.1% in the global market in 2022. It is expected to expand due to technological advancements in disease diagnosis and treatment and increasing human populations with various acute diseases like acute pain and cold symptoms, and chronic diseases like cancer and diabetes. This further increases the adoption of pharmaceutical medicines.
Overall, the use of non-sterile liquids/suspensions in human medication offers advantages like enhanced bioavailability, rapid onset of action, improved medication adherence, and flexible dosing, thus driving the global market.
Pharmaceutical companies held a market share of 33.1% in the year 2022. Pharmaceutical companies are using more non-sterile liquids/suspensions in the production of medications due to the various advantages associated with formulations in human medications and veterinary medications.
Pharmaceutical companies are taking non-sterile liquids/suspensions in bulk or package form for various applications like various dosage formulations with parenteral as well for rinsing of equipment. Apart from this, the rising number of pharmaceutical companies around the globe is another point as to which it dominates this segment.
Key players are focusing on agreements, mergers, partnerships, collaborations, and acquisitions as well as the introduction and commercialization of novel products and pharmaceuticals in order to broaden their clientele and raise business income. A few examples of strategies acquired by the key players:
Similarly, recent developments related to non-sterile liquids/suspensions market has been tracked by the team at Future Market Insights. These are available in the full report.
| Attribute | Details |
|---|---|
| Historical Data Available for | 2023 to 2033 |
| Forecast Period | 2012 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and the Middle East & Africa |
| Key Countries Covered | USA, Canada, Mexico, Brazil, Argentina, United Kingdom., Germany, Italy, Spain, France, Russia, Benelux, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, and South Africa |
| Key Market Segments Covered | Dosage Form, Application, End User, and Region |
| Key Companies Profiled | AbbVie Pharmaceutical Contract Manufacturing; Aenova Group; APPCO Pharmaceutical Corporation; Atral Pharmaceutical; Aurigene Pharmaceutical Services (Dr. Reddy’s); Biological E. Ltd.; BioPlus Life Sciences; Bora Pharmaceuticals; Cambrex Corporation; COC Farmaceutici; Contract Pharmaceuticals Limited (CPL); DPT Laboratories, Ltd.; Eurofins; JGL d.d.; Mikart; PharmaVision (Vizyon Holding); Pierre Fabre; TriRx Pharmaceutical Services; UI Pharmaceuticals; Wasdell Group; Aphena Pharma; Syngene International |
| Pricing | Available upon Request |
Table 01: Global Market Value (US$ Million) Analysis, By Dosage Form, 2012 to 2033
Table 02: Global Market Value (US$ Million) Analysis, By Application, 2012 to 2033
Table 03: Global Market Value (US$ Million) Analysis, By End User, 2012 to 2033
Table 04: Global Market Value (US$ Million) Analysis, By Region, 2012 to 2033
Table 05: North America Historical Market Value (US$ Million) Analysis, By Country, 2012 to 2033
Table 06: North America Market Value (US$ Million) Analysis, By Dosage Form, 2012 to 2033
Table 07: North America Market Value (US$ Million) Analysis, By Application, 2012 to 2033
Table 08: North America Market Value (US$ Million) Analysis, By End User, 2012 to 2033
Table 09: Latin America Historical Market Value (US$ Million) Analysis, By Country, 2012 to 2033
Table 10: Latin America Market Value (US$ Million) Analysis, By Dosage Form, 2012 to 2033
Table 11: Latin America Market Value (US$ Million) Analysis, By Application, 2012 to 2033
Table 12: Latin America Market Value (US$ Million) Analysis, By End User, 2012 to 2033
Table 13: Europe Historical Market Value (US$ Million) Analysis, By Country, 2012 to 2033
Table 14: Europe Market Value (US$ Million) Analysis, By Dosage Form, 2012 to 2033
Table 15: Europe Market Value (US$ Million) Analysis, By Application, 2012 to 2033
Table 16: Europe Market Value (US$ Million) Analysis, By End User, 2012 to 2033
Table 17: East Asia Historical Market Value (US$ Million) Analysis, By Country, 2012 to 2033
Table 18: East Asia Market Value (US$ Million) Analysis, By Dosage Form, 2012 to 2033
Table 19: East Asia Market Value (US$ Million) Analysis, By Application, 2012 to 2033
Table 20: East Asia Market Value (US$ Million) Analysis, By End User, 2012 to 2033
Table 21: South Asia Historical Market Value (US$ Million) Analysis, By Country, 2012 to 2033
Table 22: South Asia Market Value (US$ Million) Analysis, By Dosage Form, 2012 to 2033
Table 23: South Asia Market Value (US$ Million) Analysis, By Application, 2012 to 2033
Table 24: South Asia Market Value (US$ Million) Analysis, By End User, 2012 to 2033
Table 25: Oceania Historical Market Value (US$ Million) Analysis, By Country, 2012 to 2033
Table 26: Oceania Market Value (US$ Million) Analysis, By Dosage Form, 2012 to 2033
Table 27: Oceania Market Value (US$ Million) Analysis, By Application, 2012 to 2033
Table 28: Oceania Market Value (US$ Million) Analysis, By End User, 2012 to 2033
Table 29: Middle East and Africa Historical Market Value (US$ Million) Analysis, By Country, 2012 to 2033
Table 30: Middle East and Africa Market Value (US$ Million) Analysis, By Dosage Form, 2012 to 2033
Table 31: Middle East and Africa Market Value (US$ Million) Analysis, By Application, 2012 to 2033
Table 32: Middle East and Africa Market Value (US$ Million) Analysis, By End User, 2012 to 2033
Figure 01: Global Historical Market Value (US$ Million) Analysis, 2012 to 2022
Figure 02: Global Current and Future Market Value (US$ Million), 2023 to 2033 & Y-o-Y Growth Trend Analysis, 2023 to 2033
Figure 03: Global Market Absolute $ Opportunity, 2023 to 2033
Figure 04: Global Market Share Analysis (%), By Dosage Form, 2022 & 2033
Figure 05: Global Market Y-o-Y Analysis (%), By Dosage Form, 2023 to 2033
Figure 06: Market Attractiveness Analysis By Dosage Form, 2022 to 2033
Figure 07: Global Market Share Analysis (%), By Application, 2022 & 2033
Figure 08: Global Market Y-o-Y Analysis (%), By Application, 2023 to 2033
Figure 09: Market Attractiveness Analysis By Application, 2022 to 2033
Figure 10: Global Market Share Analysis (%), By End User, 2022 & 2033
Figure 11: Global Market Y-o-Y Analysis (%), By End User, 2023 to 2033
Figure 12: Market Attractiveness Analysis By End User, 2022 to 2033
Figure 13: Global Market Share Analysis (%), By Region, 2022 & 2033
Figure 14: Global Market Y-o-Y Analysis (%), By Region, 2023 to 2033
Figure 15: Market Attractiveness Analysis By Region, 2022 to 2033
Figure 16: North America Market Share Analysis (%), By Dosage Form, 2023 (E)
Figure 17: North America Market Share Analysis (%), By Application, 2023 (E)
Figure 18: North America Market Share Analysis (%), By End User, 2023 (E)
Figure 19: North America Market Share Analysis (%), By Country, 2023 (E)
Figure 20: North America Historical Market Value (US$ Million) Analysis, 2012 to 2022
Figure 21: North America Current and Future Market Value (US$ Million), 2023 to 2033 & Y-o-Y Growth Trend Analysis, 2023 to 2033
Figure 22: North America Market Share Analysis (%), By Dosage Form, 2023 (E)
Figure 23: North America Market Share Analysis (%), By Application, 2023 (E)
Figure 24: North America Market Share Analysis (%), By End User, 2023 (E)
Figure 25: North America Market Share Analysis (%), By Country, 2023 (E)
Figure 26: U.S. Market Value Proportion Analysis, 2022
Figure 27: Global Vs U.S. Y-o-Y Growth Comparison, 2023 to 2033
Figure 28: U.S. Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 29: U.S. Market Share Analysis (%) By Application, 2022 & 2033
Figure 30: U.S. Market Share Analysis (%) By End User, 2022 & 2033
Figure 31: Canada Market Value Proportion Analysis, 2022
Figure 32: Global Vs Canada Y-o-Y Growth Comparison, 2023 to 2033
Figure 33: Canada Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 34: Canada Market Share Analysis (%) By Application, 2022 & 2033
Figure 35: Canada Market Share Analysis (%) By End User, 2022 & 2033
Figure 36: Latin America Market Share Analysis (%), By Dosage Form, 2023 (E)
Figure 37: Latin America Market Share Analysis (%), By Application, 2023 (E)
Figure 38: Latin America Market Share Analysis (%), By End User, 2023 (E)
Figure 39: Latin America Market Share Analysis (%), By Country, 2023 (E)
Figure 40: Latin America Historical Market Value (US$ Million) Analysis, 2012 to 2022
Figure 41: Latin America Current and Future Market Value (US$ Million), 2023 to 2033 & Y-o-Y Growth Trend Analysis, 2023 to 2033
Figure 42: Latin America Market Share Analysis (%), By Dosage Form, 2023 (E)
Figure 43: Latin America Market Share Analysis (%), By Application, 2023 (E)
Figure 44: Latin America Market Share Analysis (%), By End User, 2023 (E)
Figure 45: Latin America Market Share Analysis (%), By Country, 2023 (E)
Figure 46: Brazil Market Value Proportion Analysis, 2022
Figure 47: Global Vs Brazil Y-o-Y Growth Comparison, 2023 to 2033
Figure 48: Brazil Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 49: Brazil Market Share Analysis (%) By Application, 2022 & 2033
Figure 50: Brazil Market Share Analysis (%) By End User, 2022 & 2033
Figure 51: Mexico Market Value Proportion Analysis, 2022
Figure 52: Global Vs Mexico Y-o-Y Growth Comparison, 2023 to 2033
Figure 53: Mexico Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 54: Mexico Market Share Analysis (%) By Application, 2022 & 2033
Figure 55: Mexico Market Share Analysis (%) By End User, 2022 & 2033
Figure 56: Argentina Market Value Proportion Analysis, 2022
Figure 57: Global Vs Argentina Y-o-Y Growth Comparison, 2023 to 2033
Figure 58: Argentina Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 59: Argentina Market Share Analysis (%) By Application, 2022 & 2033
Figure 60: Argentina Market Share Analysis (%) By End User, 2022 & 2033
Figure 61: Europe Market Share Analysis (%), By Dosage Form, 2023 (E)
Figure 62: Europe Market Share Analysis (%), By Application, 2023 (E)
Figure 63: Europe Market Share Analysis (%), By End User, 2023 (E)
Figure 64: Europe Market Share Analysis (%), By Country, 2023 (E)
Figure 65: Europe Historical Market Value (US$ Million) Analysis, 2012 to 2022
Figure 66: Europe Current and Future Market Value (US$ Million), 2023 to 2033 & Y-o-Y Growth Trend Analysis, 2023 to 2033
Figure 67: Europe Market Share Analysis (%), By Dosage Form, 2023 (E)
Figure 68: Europe Market Share Analysis (%), By Application, 2023 (E)
Figure 69: Europe Market Share Analysis (%), By End User, 2023 (E)
Figure 70: Europe Market Share Analysis (%), By Country, 2023 (E)
Figure 71: U.K. Market Value Proportion Analysis, 2022
Figure 72: Global Vs U.K. Y-o-Y Growth Comparison, 2023 to 2033
Figure 73: U.K. Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 74: U.K. Market Share Analysis (%) By Application, 2022 & 2033
Figure 75: U.K. Market Share Analysis (%) By End User, 2022 & 2033
Figure 76: Germany Market Value Proportion Analysis, 2022
Figure 77: Global Vs Germany Y-o-Y Growth Comparison, 2023 to 2033
Figure 78: Germany Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 79: Germany Market Share Analysis (%) By Application, 2022 & 2033
Figure 80: Germany Market Share Analysis (%) By End User, 2022 & 2033
Figure 81: France Market Value Proportion Analysis, 2022
Figure 82: Global Vs France Y-o-Y Growth Comparison, 2023 to 2033
Figure 83: France Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 84: France Market Share Analysis (%) By Application, 2022 & 2033
Figure 85: France Market Share Analysis (%) By End User, 2022 & 2033
Figure 86: Italy Market Value Proportion Analysis, 2022
Figure 87: Global Vs Italy Y-o-Y Growth Comparison, 2023 to 2033
Figure 88: Italy Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 89: Italy Market Share Analysis (%) By Application, 2022 & 2033
Figure 90: Italy Market Share Analysis (%) By End User, 2022 & 2033
Figure 91: Spain Market Value Proportion Analysis, 2022
Figure 92: Global Vs Spain Y-o-Y Growth Comparison, 2023 to 2033
Figure 93: Spain Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 94: Spain Market Share Analysis (%) By Application, 2022 & 2033
Figure 95: Spain Market Share Analysis (%) By End User, 2022 & 2033
Figure 96: Benelux Market Value Proportion Analysis, 2022
Figure 97: Global Vs Benelux Y-o-Y Growth Comparison, 2023 to 2033
Figure 98: Benelux Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 99: Benelux Market Share Analysis (%) By Application, 2022 & 2033
Figure 100: Benelux Market Share Analysis (%) By End User, 2022 & 2033
Figure 101: Russia Market Value Proportion Analysis, 2022
Figure 102: Global Vs Russia Y-o-Y Growth Comparison, 2023 to 2033
Figure 103: Russia Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 104: Russia Market Share Analysis (%) By Application, 2022 & 2033
Figure 105: Russia Market Share Analysis (%) By End User, 2022 & 2033
Figure 106: East Asia Market Share Analysis (%), By Dosage Form, 2023 (E)
Figure 107: East Asia Market Share Analysis (%), By Application, 2023 (E)
Figure 108: East Asia Market Share Analysis (%), By End User, 2023 (E)
Figure 109: East Asia Market Share Analysis (%), By Country, 2023 (E)
Figure 110: East Asia Historical Market Value (US$ Million) Analysis, 2012 to 2022
Figure 111: East Asia Current and Future Market Value (US$ Million), 2023 to 2033 & Y-o-Y Growth Trend Analysis, 2023 to 2033
Figure 112: East Asia Market Share Analysis (%), By Dosage Form, 2023 (E)
Figure 113: East Asia Market Share Analysis (%), By Application, 2023 (E)
Figure 114: East Asia Market Share Analysis (%), By End User, 2023 (E)
Figure 115: East Asia Market Share Analysis (%), By Country, 2023 (E)
Figure 116: China Market Value Proportion Analysis, 2022
Figure 117: Global Vs China Y-o-Y Growth Comparison, 2023 to 2033
Figure 118: China Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 119: China Market Share Analysis (%) By Application, 2022 & 2033
Figure 120: China Market Share Analysis (%) By End User, 2022 & 2033
Figure 121: Japan Market Value Proportion Analysis, 2022
Figure 122: Global Vs Japan Y-o-Y Growth Comparison, 2023 to 2033
Figure 123: Japan Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 124: Japan Market Share Analysis (%) By Application, 2022 & 2033
Figure 125: Japan Market Share Analysis (%) By End User, 2022 & 2033
Figure 126: South Korea Market Value Proportion Analysis, 2022
Figure 127: Global Vs South Korea Y-o-Y Growth Comparison, 2023 to 2033
Figure 128: South Korea Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 129: South Korea Market Share Analysis (%) By Application, 2022 & 2033
Figure 130: South Korea Market Share Analysis (%) By End User, 2022 & 2033
Figure 131: South Asia Market Share Analysis (%), By Dosage Form, 2023 (E)
Figure 132: South Asia Market Share Analysis (%), By Application, 2023 (E)
Figure 133: South Asia Market Share Analysis (%), By End User, 2023 (E)
Figure 134: South Asia Market Share Analysis (%), By Country, 2023 (E)
Figure 135: South Asia Historical Market Value (US$ Million) Analysis, 2012 to 2022
Figure 136: South Asia Current and Future Market Value (US$ Million), 2023 to 2033 & Y-o-Y Growth Trend Analysis, 2023 to 2033
Figure 137: South Asia Market Share Analysis (%), By Dosage Form, 2023 (E)
Figure 138: South Asia Market Share Analysis (%), By Application, 2023 (E)
Figure 139: South Asia Market Share Analysis (%), By End User, 2023 (E)
Figure 140: South Asia Market Share Analysis (%), By Country, 2023 (E)
Figure 141: India Market Value Proportion Analysis, 2022
Figure 142: Global Vs India Y-o-Y Growth Comparison, 2023 to 2033
Figure 143: India Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 144: India Market Share Analysis (%) By Application, 2022 & 2033
Figure 145: India Market Share Analysis (%) By End User, 2022 & 2033
Figure 146: Malaysia Market Value Proportion Analysis, 2022
Figure 147: Global Vs Malaysia Y-o-Y Growth Comparison, 2023 to 2033
Figure 148: Malaysia Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 149: Malaysia Market Share Analysis (%) By Application, 2022 & 2033
Figure 150: Malaysia Market Share Analysis (%) By End User, 2022 & 2033
Figure 151: Thailand Market Value Proportion Analysis, 2022
Figure 152: Global Vs Thailand Y-o-Y Growth Comparison, 2023 to 2033
Figure 153: Thailand Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 154: Thailand Market Share Analysis (%) By Application, 2022 & 2033
Figure 155: Thailand Market Share Analysis (%) By End User, 2022 & 2033
Figure 156: Indonesia Market Value Proportion Analysis, 2022
Figure 157: Global Vs Indonesia Y-o-Y Growth Comparison, 2023 to 2033
Figure 158: Indonesia Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 159: Indonesia Market Share Analysis (%) By Application, 2022 & 2033
Figure 160: Indonesia Market Share Analysis (%) By End User, 2022 & 2033
Figure 161: Oceania Market Share Analysis (%), By Dosage Form, 2023 (E)
Figure 162: Oceania Market Share Analysis (%), By Application, 2023 (E)
Figure 163: Oceania Market Share Analysis (%), By End User, 2023 (E)
Figure 164: Oceania Market Share Analysis (%), By Country, 2023 (E)
Figure 165: Oceania Historical Market Value (US$ Million) Analysis, 2012 to 2022
Figure 166: Oceania Current and Future Market Value (US$ Million), 2023 to 2033 & Y-o-Y Growth Trend Analysis, 2023 to 2033
Figure 167: Oceania Market Share Analysis (%), By Dosage Form, 2023 (E)
Figure 168: Oceania Market Share Analysis (%), By Application, 2023 (E)
Figure 169: Oceania Market Share Analysis (%), By End User, 2023 (E)
Figure 170: Oceania Market Share Analysis (%), By Country, 2023 (E)
Figure 171: Australia Market Value Proportion Analysis, 2022
Figure 172: Global Vs Australia Y-o-Y Growth Comparison, 2023 to 2033
Figure 173: Australia Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 174: Australia Market Share Analysis (%) By Application, 2022 & 2033
Figure 175: Australia Market Share Analysis (%) By End User, 2022 & 2033
Figure 176: New Zealand Market Value Proportion Analysis, 2022
Figure 177: Global Vs New Zealand Y-o-Y Growth Comparison, 2023 to 2033
Figure 178: New Zealand Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 179: New Zealand Market Share Analysis (%) By Application, 2022 & 2033
Figure 180: New Zealand Market Share Analysis (%) By End User, 2022 & 2033
Figure 181: Middle East and Africa Market Share Analysis (%), By Dosage Form, 2023 (E)
Figure 182: Middle East and Africa Market Share Analysis (%), By Application, 2023 (E)
Figure 183: Middle East and Africa Market Share Analysis (%), By End User, 2023 (E)
Figure 184: Middle East and Africa Market Share Analysis (%), By Country, 2023 (E)
Figure 185: Middle East and Africa Historical Market Value (US$ Million) Analysis, 2012 to 2022
Figure 186: Middle East and Africa Current and Future Market Value (US$ Million), 2023 to 2033 & Y-o-Y Growth Trend Analysis, 2023 to 2033
Figure 187: Middle East and Africa Market Share Analysis (%), By Dosage Form, 2023 (E)
Figure 188: Middle East and Africa Market Share Analysis (%), By Application, 2023 (E)
Figure 189: Middle East and Africa Market Share Analysis (%), By End User, 2023 (E)
Figure 190: Middle East and Africa Market Share Analysis (%), By Country, 2023 (E)
Figure 191: GCC Countries Market Value Proportion Analysis, 2022
Figure 192: Global Vs GCC Countries Y-o-Y Growth Comparison, 2023 to 2033
Figure 193: GCC Countries Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 194: GCC Countries Market Share Analysis (%) By Application, 2022 & 2033
Figure 195: GCC Countries Market Share Analysis (%) By End User, 2022 & 2033
Figure 196: Türkiye Market Value Proportion Analysis, 2022
Figure 197: Global Vs Türkiye Y-o-Y Growth Comparison, 2023 to 2033
Figure 198: Türkiye Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 199: Türkiye Market Share Analysis (%) By Application, 2022 & 2033
Figure 200: Türkiye Market Share Analysis (%) By End User, 2022 & 2033
Figure 201: South Africa Market Value Proportion Analysis, 2022
Figure 202: Global Vs South Africa Y-o-Y Growth Comparison, 2023 to 2033
Figure 203: South Africa Market Share Analysis (%) By Dosage Form, 2022 & 2033
Figure 204: South Africa Market Share Analysis (%) By Application, 2022 & 2033
Figure 205: South Africa Market Share Analysis (%) By End User, 2022 & 2033
From 2018 to 2022, the market registered a CAGR of 7.3%.
The market is estimated to reach USD 5.2 billion by 2033.
Human medication hold high revenue potential.
The United States, Japan, and the United Kingdom dominate the global market.
The market is forecast to register a CAGR of 6.5% through 2033.
Non-Sterile Liquids Suspensions Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
